Tag: chronic conditions

In a move that signals a significant shift toward holistic chronic disease management, Insulet Corporation, a leader in tubeless insulin pump technology, has announced a global partnership with Calm, the prominent mental health and meditation platform. This collaboration, unveiled on July 14, represents the first integrated content partnership between a medical technology (MedTech) company and…

The upcoming ENDO 2026 conference represents a rare and significant milestone in the field of endocrinology, as it features the converging research of a father and son whose separate academic paths have led them to the same biological intersection. Dr. Daniel Dumesic, a renowned expert in reproductive endocrinology at the David Geffen School of Medicine…

The field of endocrinology is currently undergoing a period of profound transformation, marked by a shift toward more personalized patient care, the rebranding of long-standing clinical conditions, and the discovery of multi-systemic benefits for existing pharmacological treatments. From the halls of prestigious medical conferences to the front lines of community health centers, endocrinologists are redefining…

The July edition of Endocrine News marks the return of its highly anticipated Early-Career issue, a dedicated publication that shines a spotlight on the emerging voices and transformative research within the global endocrinology community. As the field of hormone research and clinical practice undergoes rapid evolution—driven by breakthroughs in metabolic medicine, genetic sequencing, and patient-centered…

The annual ENDO 2026 meeting, hosted by the Endocrine Society, once again served as a premier global stage for the unveiling of transformative research in the field of endocrinology. Among the most anticipated sessions of the conference was the Rising Star Power Talks, a high-stakes, "blitz-style" competition designed to provide a national platform for early-career…

In June, the American Medical Association (AMA) House of Delegates convened in Chicago, Illinois, to deliberate and establish critical policy positions that will shape the landscape of American healthcare for years to come. Representing the specialized interests of the endocrine community, the Endocrine Society dispatched a delegation comprising Naykky Singh Ospina, MD, Amanda Bell, MD,…

The landscape of endocrinology research is undergoing a profound transformation as a new generation of laboratory technologies redefines the boundaries of precision, sensitivity, and operational efficiency. In an era where the smallest physiological variation can signal the difference between health and chronic disease, the demand for high-fidelity analytical tools has never been more urgent. Modern…

Led by Karine Gauthier, PhD, the research team explored how transient periods of hypothyroidism—specifically during the final stages of pregnancy and the initial weeks of lactation—affect the developmental trajectory and adult metabolic health of offspring. The study highlights that while the medical community has long recognized the dangers of thyroid hormone (TH) deficiency during pregnancy,…

The medical community has long operated under the assumption that significant weight loss naturally precipitates an increase in physical activity, as the reduced physical burden on the joints and cardiovascular system theoretically makes movement easier. However, groundbreaking research presented at the ENDO 2026 annual meeting suggests a paradoxical trend among those utilizing glucagon-like peptide-1 (GLP-1)…

A comprehensive retrospective cohort study presented at the ENDO 2026 annual meeting has uncovered significant fluctuations in how patients utilize glucagon-like peptide-1 (GLP-1) receptor agonists. The research, which analyzed the treatment patterns of more than 60,000 Americans, suggests that the use of these blockbuster medications is far less linear than previously assumed by the medical…